Momenta Pharma Could Face Pressure Following Approval Of Mylan's Generic Copaxone
October 05, 2017 at 08:58 AM EDT
The U.S. Food and Drug Administration's approval of Mylan N.V. (NASDAQ: MYL)'s generic version of Copaxone for the treatment of ...